Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres (Q44794986)
Jump to navigation
Jump to search
scientific article published in April 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres |
scientific article published in April 2004 |
Statements
1 reference
Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres (English)
1 reference
Roy S Herbst
1 reference
Erminia Massarelli
1 reference
Frank V Fossella
1 reference
Ralph G Zinner
1 reference
Bonnie S Glisson
1 reference
Katherine M W Pisters
1 reference
Merril S Kies
1 reference
Pamela M Lee
1 reference
Bradley Sabloff
1 reference
Herbert A Fritsche
1 reference
Jae Y Ro
1 reference
Nelson G Ordonez
1 reference
Hai T Tran
1 reference
Ying Yang
1 reference
Terry L Smith
1 reference
Robert D Mass
1 reference
1 April 2004
1 reference
1 reference
Identifiers
1 reference